Jeff leads the Oncology and Virology Practices at Cello Health BioConsulting, formerly Defined Health. The cancer practice is BioConsulting’s largest therapeutic area.
Before joining Cello Health, Jeff was a Senior Research Scientist and Research Project Leader in the commercial development of oligonucleotide therapeutics for viral diseases and cancer at Innovir Laboratories; and an Assistant Research Professor at The George Washington University School of Medicine.
He received a BA from University of California at San Diego, and a PhD in Medical Microbiology from the University of California at Berkeley, working with Drs. David Kingsbury and Stanley Prusiner on prions. He also earned an MA in English/Creative Writing from New York University.
Jeff is a member of the Licensing Executives Society (LES), the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the American Society of Gene and Cell Therapy (ASGCT), The Society for Immunotherapy of Cancer (SITC), and the New York Academy of Sciences (NYAS).
Mark Haines, Global IT Director, on working collaboratively with dynamic teams across Cello Health, and what makes us a Sunday Times Top company to work for.
Profile: Beth Fordham-Meier, VP Business Development, Cello Health BioConsulting
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us